[4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate

C145H259F6N9O31 — CID 159172363

IUPAC[4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate
SMILESCC(=O)N(C(=O)C(C)(C)C)C1CC(C)(C)N(OC(=O)C(C)(C)C)C(C)(C)C1.CC(=O)ON1C(C)(C)CC2(CC1(C)C)OCC(C)(C)CO2.CC1(C)CC(OC(=O)C(F)(F)F)CC(C)(C)N1OC(=O)C(F)(F)F.CCC1(C)CC2(CC(C)(CC)N1OC(C)=O)OCCO2.CCC1(COC(C)=O)COC2(CC(C)(CC)N(OC(C)=O)C(C)(CC)C2C)OC1.CCCCCCCCCCCCCCCCCC(=O)OCC1(CC)COC2(CC(C)(CC)N(OC(C)=O)C(C)(CC)C2C)OC1.CCCCN(C(C)=O)C1CC(C)(C)N(OC(=O)C(C)(C)C)C(C)(C)C1
InChIInChI=1S/C38H71NO6.C22H39NO6.C21H38N2O4.C20H38N2O3.C16H29NO4.C15H27NO4.C13H17F6NO4/c1-9-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27-34(41)42-29-37(12-4)30-43-38(44-31-37)28-35(7,10-2)39(45-33(6)40)36(8,11-3)32(38)5;1-9-19(7)12-22(16(4)20(8,10-2)23(19)29-18(6)25)27-14-21(11-3,15-28-22)13-26-17(5)24;1-14(24)22(16(25)18(2,3)4)15-12-20(8,9)23(21(10,11)13-15)27-17(26)19(5,6)7;1-10-11-12-21(15(2)23)16-13-19(6,7)22(20(8,9)14-16)25-17(24)18(3,4)5;1-12(18)21-17-14(4,5)8-16(9-15(17,6)7)19-10-13(2,3)11-20-16;1-6-13(4)10-15(18-8-9-19-15)11-14(5,7-2)16(13)20-12(3)17;1-10(2)5-7(23-8(21)12(14,15)16)6-11(3,4)20(10)24-9(22)13(17,18)19/h32H,9-31H2,1-8H3;16H,9-15H2,1-8H3;15H,12-13H2,1-11H3;16H,10-14H2,1-9H3;8-11H2,1-7H3;6-11H2,1-5H3;7H,5-6H2,1-4H3
InChIKeyKLVULHGQZMRYRW-UHFFFAOYSA-N
MW2738.69 g/mol
LogP30.69
Rot. Bonds41

About [4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate

[4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate (PubChem CID 159172363) has the molecular formula C145H259F6N9O31 and a molecular weight of 2738.69 g/mol. Its IUPAC name is [4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate.

Molecular Properties

Compound Name[4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate
PubChem CID159172363
Molecular FormulaC145H259F6N9O31
Molecular Weight2738.69 g/mol
Exact Mass2736.89
IUPAC Name[4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate
SMILESCC(=O)N(C(=O)C(C)(C)C)C1CC(C)(C)N(OC(=O)C(C)(C)C)C(C)(C)C1.CC(=O)ON1C(C)(C)CC2(CC1(C)C)OCC(C)(C)CO2.CC1(C)CC(OC(=O)C(F)(F)F)CC(C)(C)N1OC(=O)C(F)(F)F.CCC1(C)CC2(CC(C)(CC)N1OC(C)=O)OCCO2.CCC1(COC(C)=O)COC2(CC(C)(CC)N(OC(C)=O)C(C)(CC)C2C)OC1.CCCCCCCCCCCCCCCCCC(=O)OCC1(CC)COC2(CC(C)(CC)N(OC(C)=O)C(C)(CC)C2C)OC1.CCCCN(C(C)=O)C1CC(C)(C)N(OC(=O)C(C)(C)C)C(C)(C)C1
InChIInChI=1S/C38H71NO6.C22H39NO6.C21H38N2O4.C20H38N2O3.C16H29NO4.C15H27NO4.C13H17F6NO4/c1-9-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27-34(41)42-29-37(12-4)30-43-38(44-31-37)28-35(7,10-2)39(45-33(6)40)36(8,11-3)32(38)5;1-9-19(7)12-22(16(4)20(8,10-2)23(19)29-18(6)25)27-14-21(11-3,15-28-22)13-26-17(5)24;1-14(24)22(16(25)18(2,3)4)15-12-20(8,9)23(21(10,11)13-15)27-17(26)19(5,6)7;1-10-11-12-21(15(2)23)16-13-19(6,7)22(20(8,9)14-16)25-17(24)18(3,4)5;1-12(18)21-17-14(4,5)8-16(9-15(17,6)7)19-10-13(2,3)11-20-16;1-6-13(4)10-15(18-8-9-19-15)11-14(5,7-2)16(13)20-12(3)17;1-10(2)5-7(23-8(21)12(14,15)16)6-11(3,4)20(10)24-9(22)13(17,18)19/h32H,9-31H2,1-8H3;16H,9-15H2,1-8H3;15H,12-13H2,1-11H3;16H,10-14H2,1-9H3;8-11H2,1-7H3;6-11H2,1-5H3;7H,5-6H2,1-4H3
InChIKeyKLVULHGQZMRYRW-UHFFFAOYSA-N
XLogP30.69
TPSA417.21 Ų
H-Bond Donors
H-Bond Acceptors38
Rotatable Bonds41
Heavy Atoms191
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002738.69
LogP ≤ 530.69
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1038

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze [4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate?
The IUPAC name of [4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate (CID 159172363) is [4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate.
What is the SMILES notation for [4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate?
The canonical SMILES for [4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate is CC(=O)N(C(=O)C(C)(C)C)C1CC(C)(C)N(OC(=O)C(C)(C)C)C(C)(C)C1.CC(=O)ON1C(C)(C)CC2(CC1(C)C)OCC(C)(C)CO2.CC1(C)CC(OC(=O)C(F)(F)F)CC(C)(C)N1OC(=O)C(F)(F)F.CCC1(C)CC2(CC(C)(CC)N1OC(C)=O)OCCO2.CCC1(COC(C)=O)COC2(CC(C)(CC)N(OC(C)=O)C(C)(CC)C2C)OC1.CCCCCCCCCCCCCCCCCC(=O)OCC1(CC)COC2(CC(C)(CC)N(OC(C)=O)C(C)(CC)C2C)OC1.CCCCN(C(C)=O)C1CC(C)(C)N(OC(=O)C(C)(C)C)C(C)(C)C1.
What is the InChIKey of [4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate?
The InChIKey is KLVULHGQZMRYRW-UHFFFAOYSA-N. The full InChI is InChI=1S/C38H71NO6.C22H39NO6.C21H38N2O4.C20H38N2O3.C16H29NO4.C15H27NO4.C13H17F6NO4/c1-9-13-14-15-16-17-18-19-20-21-22-23-24-25-26-27-34(41)42-29-37(12-4)30-43-38(44-31-37)28-35(7,10-2)39(45-33(6)40)36(8,11-3)32(38)5;1-9-19(7)12-22(16(4)20(8,10-2)23(19)29-18(6)25)27-14-21(11-3,15-28-22)13-26-17(5)24;1-14(24)22(16(25)18(2,3)4)15-12-20(8,9)23(21(10,11)13-15)27-17(26)19(5,6)7;1-10-11-12-21(15(2)23)16-13-19(6,7)22(20(8,9)14-16)25-17(24)18(3,4)5;1-12(18)21-17-14(4,5)8-16(9-15(17,6)7)19-10-13(2,3)11-20-16;1-6-13(4)10-15(18-8-9-19-15)11-14(5,7-2)16(13)20-12(3)17;1-10(2)5-7(23-8(21)12(14,15)16)6-11(3,4)20(10)24-9(22)13(17,18)19/h32H,9-31H2,1-8H3;16H,9-15H2,1-8H3;15H,12-13H2,1-11H3;16H,10-14H2,1-9H3;8-11H2,1-7H3;6-11H2,1-5H3;7H,5-6H2,1-4H3.
What are the key properties of [4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate?
[4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate has a molecular weight of 2738.69 g/mol, XLogP of 30.69, 41 rotatable bonds, 0 hydrogen bond donors, and 38 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[acetyl(butyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;[4-[acetyl(2,2-dimethylpropanoyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl] 2,2-dimethylpropanoate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl acetate;(9-acetyloxy-3,8,10-triethyl-8,10,11-trimethyl-1,5-dioxa-9-azaspiro[5.5]undecan-3-yl)methyl octadecanoate;(7,9-diethyl-7,9-dimethyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl) acetate;(3,3,8,8,10,10-hexamethyl-1,5-dioxa-9-azaspiro[5.5]undecan-9-yl) acetate;[2,2,6,6-tetramethyl-1-(2,2,2-trifluoroacetyl)oxypiperidin-4-yl] 2,2,2-trifluoroacetate is sourced from PubChem (CID 159172363), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).